MiMedx Group, Inc. Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- MiMedx Group, Inc. treasury stock, value, acquired, cost method for the quarter ending 2026-06-30 was $12.86M.
- MiMedx Group, Inc. treasury stock, value, acquired, cost method for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- MiMedx Group, Inc. treasury stock, value, acquired, cost method for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- MiMedx Group, Inc. treasury stock, value, acquired, cost method for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- MiMedx Group, Inc. treasury stock, value, acquired, cost method for fiscal 2018 was $7.57M, a 88.91% decline from fiscal 2017.
- MiMedx Group, Inc. treasury stock, value, acquired, cost method for fiscal 2017 was $68.26M, a 557.77% increase from fiscal 2016.
- MiMedx Group, Inc. treasury stock, value, acquired, cost method for fiscal 2016 was $10.38M, a 74.23% decline from fiscal 2015.
- MiMedx Group, Inc. treasury stock, value, acquired, cost method for fiscal 2015 was $40.28M, a 617.73% increase from fiscal 2014.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2026-06-30 | $12.86M 10-Q · filed 2026-07-29 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $7.57M 10-K · filed 2021-03-08 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-07-06 | $31.80M derived: sum of 4 quarters · filed 2020-07-06 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-06 | $61.09M derived: sum of 4 quarters · filed 2020-07-06 |
| 2018-03-31 | $7.57M 10-Q · filed 2020-07-06 | $63.17M derived: sum of 4 quarters · filed 2020-07-06 |
| 2017-12-31 | $24.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-06 | $68.26M 10-K · filed 2020-07-06 |
| 2017-09-30 | $29.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $44.03M derived: sum of 4 quarters · filed 2020-03-17 |
| 2017-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | $21.59M derived: sum of 4 quarters · filed 2020-03-17 |
| 2017-03-31 | $12.67M 10-Q · filed 2017-05-01 | $19.51M derived: sum of 4 quarters · filed 2020-03-17 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $10.38M 10-K · filed 2020-03-17 |
| 2016-09-30 | $6.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $29.59M derived: sum of 4 quarters · filed 2017-03-01 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $27.17M derived: sum of 4 quarters · filed 2017-03-01 |
| 2016-03-31 | $3.53M 10-Q · filed 2016-05-10 | $31.51M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-12-31 | $19.21M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $40.28M 10-K · filed 2017-03-01 |
| 2015-09-30 | $4.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | |
| 2015-06-30 | $4.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | |
| 2015-03-31 | $12.29M 10-Q · filed 2015-05-01 | |
| 2014-12-31 | $5.61M 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |